Small Molecules

RayBiotech offers > 5,000 small molecules that act as agonists, substrates, activators, and inhibitors in many pathways and processes, including:

• Angiogenesis
• Apoptosis
• Autophagy
• Cancer
• Cell cycle
• Cell metabolism
• DNA damage
• GPCR pathway
• Inflammation
• JAK/STAT pathway
• MAPK pathway
• Neuroscience
• mTOR pathway
• NF-kB pathway
• TGF-beta pathway
• And more!

Gleevec (imatinib mesylate) binds to and inhibits the activity of BCR-ABL, a tyrosine kinase relevant in cancer and other diseases